Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J R Schaefer

Showing results (1-10 of 47) with videos related to

Pageof 5
Sort By:
Herz|February 1, 2002
[Drug therapy of hyperlipidemia. Current status in Germany]J R Schaefer
Herz|January 20, 2012
[HDL level or HDL function as the primary target in preventive cardiology]J R Schaefer
Dentistry (American Student Dental Association)|April 1, 1992
The American Dental Association: meeting your personal and professional needsJ R Schaefer
Lancet (London, England)|May 16, 2003
Homozygous familial hypercholesterolaemia in identical twinsJ Zschocke, J R Schaefer
Herz|July 1, 1998
[Arteriosclerosis and coronary heart disease--strengths and weaknesses in the classical risk factor concept]J R Schaefer, M Herzum
Deutsche Medizinische Wochenschrift (1946)|December 16, 2010
[New approaches to lecture medicine--or: what can we learn from television?]J R Schaefer, A Jerrentrup, A Neubauer
The New England Journal of Medicine|December 29, 1998
Association of mutations in the apolipoprotein B gene with hypercholesterolemia and the risk of ischemic heart diseaseJ R Schaefer, M Herzum, B Maisch
Zeitschrift Fur Kardiologie|October 3, 2000
[Impediment of cellular immune response under treatment with ticlopidine in a patient with Staphylococcus aureus endocarditis]P Alter, J R Schaefer, B Maisch
Herz|March 27, 1999
[Prevention of coronary heart disease--"evidence-based medicine" of antilipemic therapy]J R Schaefer, M Herzum, B Maisch
Herz|July 1, 1998
[Cytomegalovirus and herpes simplex virus in pathogenesis and progression of native arteriosclerosis and recurrent stenosis after intervention]M Herzum, J R Schaefer, G Hufnagel, et al.
Pageof 5

Showing results (1-10 of 47) with videos related to

Sort By:
Pageof 5
Herz|February 1, 2002
[Drug therapy of hyperlipidemia. Current status in Germany]J R Schaefer
Herz|January 20, 2012
[HDL level or HDL function as the primary target in preventive cardiology]J R Schaefer
Dentistry (American Student Dental Association)|April 1, 1992
The American Dental Association: meeting your personal and professional needsJ R Schaefer
Lancet (London, England)|May 16, 2003
Homozygous familial hypercholesterolaemia in identical twinsJ Zschocke, J R Schaefer
Herz|July 1, 1998
[Arteriosclerosis and coronary heart disease--strengths and weaknesses in the classical risk factor concept]J R Schaefer, M Herzum
Deutsche Medizinische Wochenschrift (1946)|December 16, 2010
[New approaches to lecture medicine--or: what can we learn from television?]J R Schaefer, A Jerrentrup, A Neubauer
The New England Journal of Medicine|December 29, 1998
Association of mutations in the apolipoprotein B gene with hypercholesterolemia and the risk of ischemic heart diseaseJ R Schaefer, M Herzum, B Maisch
Zeitschrift Fur Kardiologie|October 3, 2000
[Impediment of cellular immune response under treatment with ticlopidine in a patient with Staphylococcus aureus endocarditis]P Alter, J R Schaefer, B Maisch
Herz|March 27, 1999
[Prevention of coronary heart disease--"evidence-based medicine" of antilipemic therapy]J R Schaefer, M Herzum, B Maisch
Herz|July 1, 1998
[Cytomegalovirus and herpes simplex virus in pathogenesis and progression of native arteriosclerosis and recurrent stenosis after intervention]M Herzum, J R Schaefer, G Hufnagel, et al.
Pageof 5